Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III Study of CS-8958 in Pediatric Patients With Influenza
jRCT2080220783Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of laninamivir in influenza (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
laninamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080220783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220783.